EmSense Raises $9 Million Series C Round of Financing

Tue Nov 3, 2009 10:31am EST

* Reuters is not responsible for the content in this press release.

Technology Partners Leads Investment




SAN FRANCISCO, Nov. 3 /PRNewswire/ -- EmSense Corporation, the company that
created the first scalable physiological and brainwave measurement technology,
today announced the completion of a $9 Million Series C round of funding, led
by an investment from Technology Partners with existing investor the Foundry
Group also participating.

This funding will allow EmSense to continue its global expansion in support of
its many market research partners.  The funds will also enable the company to
develop a large bio-sensory in-home panel - the first of its kind.  

"We believe that neuromarketing is now mainstream and is poised for explosive
growth. Over the past year we conducted extensive diligence on the
neuromarketing space and chose EmSense based on their highly-scalable business
model, numerous clients, and key market research partners," said Roger Quy,
general partner with Technology Partners.

"We are especially pleased to welcome Technology Partners as well-respected
investors and valued partners as EmSense enters a period of very rapid growth.
 Roger Quy may be one of the only venture capitalists with a PhD in
neuroscience and a research background in neurotechnology; and, as such, is
particularly well suited to advise our company.  This is yet another
endorsement of our science, technology, and business model," said Keith
Winter, president & CEO of EmSense.  "We are also very happy to have Foundry
Group's continued support in this round."

"Foundry Group is very excited to complete a follow-on investment in what we
see as the dominant player in the rapidly expanding neuromarketing industry. 
Furthermore, EmSense represents a key company in our human-computer
interaction investment theme, which focuses on the ongoing evolution in the
way humans interact with their computing devices - well beyond the keyboard
and mouse, " said Ryan McIntyre, managing director at Foundry Group and
EmSense board member.

About EmSense 

EmSense is a leading-edge neuroscience company that applies advances in EEG
and other neurometrics to provide clients with deep and reliable understanding
of consumers' emotional and cognitive engagement with marketing stimuli. The
company's quantitative metrics deliver breakthrough insights that facilitate
the creation and optimization of advertising, packaging, media content, online
marketing, and both the live in-store and virtual store shopping experiences. 
EmSense provides expertise and advancements in emotion tracking, cognitive
neuroscience, analytics, and market research through their proprietary
EmGear(TM), the first ever dry, wireless, scalable, non-invasive EEG
neuroscience technology.  EmSense is headquartered in San Francisco.  To learn
more about EmSense's technology solutions and consulting services, visit
www.emsense.com.

About Technology Partners

Founded 25 years ago, Technology Partners manages a total of approximately
$700 million of venture capital and is currently investing from Technology
Partners VIII, a 2007 fund. Investments are targeted in the areas of cleantech
and life science, with a particular focus in neurotechnology and consumer
medicine.

About Foundry Group 

Foundry Group is a venture capital firm focused on making investments in
early-stage information technology, Internet, and software startups.  Foundry
Group's current venture fund of $225m was launched in late 2007.  The firm is
located in Boulder, Colorado, and invests throughout North America.



SOURCE  EmSense Corporation

Meredith Bradford of EmSense Corporation, +1-303-993-5018, press@emsense.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.